Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review

BACKGROUND: KRAS mutations in codons 12 and 13 are established predictive biomarkers for anti-EGFR therapy in colorectal cancer. Previous studies suggest that KRAS codon 61 and 146 mutations may also predict resistance to anti-EGFR therapy in colorectal cancer. However, clinicopathological, molecula...

Descripción completa

Detalles Bibliográficos
Autores principales: Imamura, Yu, Lochhead, Paul, Yamauchi, Mai, Kuchiba, Aya, Qian, Zhi Rong, Liao, Xiaoyun, Nishihara, Reiko, Jung, Seungyoun, Wu, Kana, Nosho, Katsuhiko, Wang, Yaoyu E, Peng, Shouyong, Bass, Adam J, Haigis, Kevin M, Meyerhardt, Jeffrey A, Chan, Andrew T, Fuchs, Charles S, Ogino, Shuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051153/
https://www.ncbi.nlm.nih.gov/pubmed/24885062
http://dx.doi.org/10.1186/1476-4598-13-135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051153/
https://www.ncbi.nlm.nih.gov/pubmed/24885062
http://dx.doi.org/10.1186/1476-4598-13-135

Ejemplares similares